EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Discontinuing Immune Checkpoint Inhibitor–Based Therapy After Complete Response in Unresectable Hepatocellular Carcinoma: Evidence, Bias, and a Research Framework

Yujia He, Zhe Wang

Journal of Hepatocellular Carcinoma · 2026-10 · Volume 13 · 1-24

DOI: 10.2147/jhc.s645986 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-10. Verfasst von Yujia He und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Hospital of China Medical University, Shenyang, 110001, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

competing riskscomplete responsehepatocellular carcinomaimmune checkpoint inhibitormRECISTtarget-trial emulationtreatment discontinuationtreatment-free remission

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Hospital of China Medical University, Shenyang, 110001, People's Republic of China.
  • Department of Orthopedics, The First Hospital of China Medical University, Shenyang, 110001, People's Republic of China.

Zitieren

APA

He, Y., & Wang, Z. (2026). Discontinuing Immune Checkpoint Inhibitor–Based Therapy After Complete Response in Unresectable Hepatocellular Carcinoma: Evidence, Bias, and a Research Framework. Journal of Hepatocellular Carcinoma, Volume 13, 1-24. https://doi.org/10.2147/jhc.s645986

Vancouver

He Y, Wang Z. Discontinuing Immune Checkpoint Inhibitor–Based Therapy After Complete Response in Unresectable Hepatocellular Carcinoma: Evidence, Bias, and a Research Framework. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-24. doi:10.2147/jhc.s645986

BibTeX
@article{He2026,
  author = {He, Yujia and Wang, Zhe},
  title = {Discontinuing Immune Checkpoint Inhibitor–Based Therapy After Complete Response in Unresectable Hepatocellular Carcinoma: Evidence, Bias, and a Research Framework},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--24},
  doi = {10.2147/jhc.s645986}
}
Kostenlos starten →